Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (111-120 of 212) with videos related to

Pageof 22
Sort By:
American Heart Journal|April 1, 2009
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarctionAbhinav Goyal, Shamir R Mehta, Hertzel C Gerstein, et al.
The New England Journal of Medicine|September 8, 2010
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, Shamir R Mehta, Jean-Pierre Bassand, et al.
Journal of Thrombosis and Thrombolysis|November 25, 2017
Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCIAndrew Yang, Quin Pon, Andrea Lavoie, et al.
Journal of the American Heart Association|November 5, 2017
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionMatthias Bossard, Christopher B Granger, Jean-Francois Tanguay, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
CMAJ Open|November 3, 2020
Using the clinical chemistry score in the emergency department to detect adverse cardiac events: a diagnostic accuracy studyPeter A Kavsak, Joshua O Cerasuolo, Dennis T Ko, et al.
Heart (British Cardiac Society)|January 28, 2021
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseMatthias Bossard, Peggy Gao, William Boden, et al.
American Heart Journal|March 30, 2013
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) studyAkshay Bagai, Warren J Cantor, Mary Tan, et al.
Journal of the American College of Cardiology|November 26, 2013
Procedural volume and outcomes with radial or femoral access for coronary angiography and interventionSanjit S Jolly, John Cairns, Salim Yusuf, et al.
Circulation. Cardiovascular Interventions|April 10, 2015
Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized TrialDean J Kereiakes, Ian T Meredith, Stephan Windecker, et al.
Pageof 22

Showing results (111-120 of 212) with videos related to

Sort By:
Pageof 22
American Heart Journal|April 1, 2009
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarctionAbhinav Goyal, Shamir R Mehta, Hertzel C Gerstein, et al.
The New England Journal of Medicine|September 8, 2010
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, Shamir R Mehta, Jean-Pierre Bassand, et al.
Journal of Thrombosis and Thrombolysis|November 25, 2017
Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCIAndrew Yang, Quin Pon, Andrea Lavoie, et al.
Journal of the American Heart Association|November 5, 2017
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionMatthias Bossard, Christopher B Granger, Jean-Francois Tanguay, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
CMAJ Open|November 3, 2020
Using the clinical chemistry score in the emergency department to detect adverse cardiac events: a diagnostic accuracy studyPeter A Kavsak, Joshua O Cerasuolo, Dennis T Ko, et al.
Heart (British Cardiac Society)|January 28, 2021
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseMatthias Bossard, Peggy Gao, William Boden, et al.
American Heart Journal|March 30, 2013
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) studyAkshay Bagai, Warren J Cantor, Mary Tan, et al.
Journal of the American College of Cardiology|November 26, 2013
Procedural volume and outcomes with radial or femoral access for coronary angiography and interventionSanjit S Jolly, John Cairns, Salim Yusuf, et al.
Circulation. Cardiovascular Interventions|April 10, 2015
Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized TrialDean J Kereiakes, Ian T Meredith, Stephan Windecker, et al.
Pageof 22